Canada: And The Times They Are A'Changing The Evolution Of Insurance Coverage For Medical Marijuana – Update

Last Updated: November 10 2017
Article by Helen D.K. Friedman

In our previous publication[1], we discussed the incremental extension of coverage for medical marijuana under various types of insurance benefit plans and recent caselaw regarding insurer funding for medical marijuana.

By way of update, Skinner v. Board of Trustees of the Canadian Elevator Industry Welfare Trust Fund [2], a 2017 decision of the Nova Scotia Human Rights Commission (NSHRC), was appealed by the Board of Trustees.  The appeal was heard October 2, 2017, by the Nova Scotia Court of Appeal and a decision is pending.  The appeal was "supported" financially and strategically by Aurora Cannabis Inc. and CFAMM (Canadians for Fair Access to Medical Marijuana)[3].

Those with intervenor status include 12 large Atlantic Canada-based employers including Irving Shipbuilding, Sobeys Inc., Medavie Blue Cross, and 12 other Welfare Benefit plans.  The Nova Scotia Human Rights Tribunal, as well as The National ME/FM Network, a group which represents people across Canada with chronic pain, also intervened.  The magnitude of interest reflects the need for the insurance industry to tune into the ramifications of coverage, both from an approval and denial perspective.

Skinner, injured in an automobile accident in the course of employment, developed chronic pain, anxiety and depression refractory to conventional treatment.  Workers Compensation denied his claim and an appeal was pending.  In the interim, his employer's auto insurer funded medical marijuana for Mr. Skinner for approximately two years.  When he reached his policy maximum of $25,000.00, Mr. Skinner applied to the Trust as his group benefits provider for funding of medical marijuana but was denied.  He applied to the NSHRC alleging discrimination by the Trust in denying his claim.

While the NSHRC found the Trust to have discriminated against Skinner in refusing to fund his medical marijuana, the impact of the decision may be particular to Nova Scotia as their Human Rights legislation does not contain the same benefit plan exclusions as other jurisdictions.  The NSHRC had evidence that the Nova Scotia Ministry of Community and Social Services was required to pay for medical marijuana as a "special need" under the Employment Support and Income Assistance Act and medical marijuana was a compensable drug under the New Brunswick Workers' Compensation Act.  The NSHRC was hampered by a lack of evidence as to any undue financial hardship to the Welfare Trust if coverage for medical marijuana was imposed.  Presumably, evidence could be marshalled on both sides with respect to the financial impact.  The NSHRC specified their decision did not imply other benefit plans should cover medical marijuana.  Their decision was limited to the effects of the denial in the face of the wording of the Trust plan, acknowledging alternate wording could effectively exclude coverage.

The most significant barrier to medical marijuana coverage, as indicated in our earlier publication and raised by the Trust, is the absence of a Drug Identification Number (DIN).  Without a DIN, coverage as a medication is unlikely.  A number of benefit plans provide for individual healthcare spending accounts (HSA) which allow an annual discretionary amount for "approved medical expenses".  The HSA allows plan members to be reimbursed for eligible out of pocket, health-related expenses not covered by their extended health and dental plans.  Reportedly, medical marijuana is listed as an eligible expense in many HSAs.

Some HSAs base their eligible medical benefits on the Canada Revenue Agency (CRA) list of eligible medical expenses.  As of 2015, CRA has confirmed that medical marijuana purchased under appropriate authorization is an allowable medical expense at tax time.  The CRA website includes medical marijuana and marijuana seeds as eligible expenses.  For those without benefit coverage but with a medical marijuana authorization, the cost can be mitigated as an allowable medical expense above a certain threshold. That said, the taxpayer still has to fund the product to begin with.

Intervention in Skinner by the National ME/FM Action Network may signal an opportunity for a more fulsome consideration of the broader cost/benefits of coverage inclusion.  The Journal of Pain (official journal of the American Pain Society)[4] in June 2016 referenced a study which suggests that many chronic pain patients were substituting medical marijuana for opioids and other medication and finding the benefit of medical marijuana to be greater than opioids.  The article suggests that using medical marijuana for chronic pain may result in decreased opioid use.  While the initial study requires further investigation, insurers could potentially benefit by covering the cost of medical marijuana if it would reduce costs connected with prescription opioids.  Most if not all prescription opioids are covered under benefit plans.   Potentially, coverage extension for medical marijuana may lead to reduced benefit and societal costs connected to prescription opioids.

The level of interest in the Skinner appeal and the implications for employers, welfare trusts and insurers is a sign that the times, they are a'changing.  As a result, insurers are being called upon to review their policy wordings and determine whether medical marijuana is a product which will be covered and if so, under what circumstances and at what cost.  Legalization of recreational marijuana in July 2018 is likely to play a part in the analysis.

Footnotes

[1] a Claims Canada August/September 2017, Volume II, No. 4.

1b Miller Thomson Insurance Law blog, July 24, 2017

[2] 2017 CanLII 3240 (NSHRC)

[3] CFAMM Media Release, September 28, 2017

[4] The Journal of Pain, June 2016, Volume 17, Issue 6 "Medical Cannabis Use is Associated with Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients with Chronic Pain" – Kevin F. Boehnke, Evangelos Litinas, Daniel J. Clauw.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Helen D.K. Friedman
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions